Understanding A1C

How Diabetes is Diagnosed and Monitored

What is A1C?

The A1C test measures your average blood sugar for the past 2-3 months. It can identify prediabetes, it can diagnose diabetes, and it’s used to monitor how well your diabetes treatment is working over time.

Diabetes is diagnosed at an A1C of greater than or equal to 6.5%

Information from American Diabetes Association

Reading your A1C

A1C test results are reported as a percentage. The higher the percentage, the higher your blood sugar levels over the past two to three months. The A1C test can also be used for diagnosis, based on the following guidelines:

A1C Ranges

Normal: <5.7%

Prediabetes: 5.7% to 6.4%

Diabetes: 6.5%+

The A1C test can help you manage your diabetes by:

Confirming self-testing results or blood test results by the doctor.
Judging whether a treatment plan is working.
Showing you how healthy choices can make a difference in diabetes control.

A1C is also defined as Estimated Average Glucose, or eAG

When finding out your A1C, you may also encounter the term “eAG.” eAG is similar to what you see when testing your blood sugar on your meter. Since you are more likely to check your blood sugar in the morning or before meals, your at-home meter readings will probably be lower than your eAG.

How does A1C work?

Hemoglobin is a protein found inside red blood cells that links up with glucose. Hemoglobin takes oxygen from the lungs to your body’s cells. When glucose enters your red blood cells, it links up or “glycates” with hemoglobin. The more glycated hemoglobin you have in your blood, the more glucose is present. By measuring the percentage of A1C in the blood, you can see how your body regulates blood sugar over time.

Do you have questions about Restor Metabolix?

Contact Us And A Member Of Our Team Will Be With You Shortly!

About Jeffrey Smith

Jeffrey A. Smith was named President and CEO of One Direct Health Network, Inc. and T-Rex Investment, Inc. in April of 2017. Under his leadership, the company has more than doubled its revenues and were EBITDA positive in 2018. The company is building out a post-operative care “Platform to improve patient outcomes, while reducing cost in the Workers Comp and VA arena. Prior to accepting this position, he briefly acting as the Chairman of the Executive Committee of Amendia from June, 2016 to January, 2017. As Chairman, Jeff’s responsibilities include mergers and acquisitions, strategic planning, and investing in new IP. Mr. Smith held the title of Amendia CEO and Director for seven years. Under Jeff’s leadership, Amendia was recognized by multiple awards from Atlanta’s Best And Brightest Companies to Work For, 2016, Atlanta Business Chronicle’s Fast 40 Companies in Atlanta, 2012 and 2013, Deloitte’s Tech Fast 500, 2014 and 2015, and Georgia Manufacturers of the Year, 2014. Under his guidance, Amendia grew from $2.9 million in Revenue to over $82.5 million in seven years and was instrumental in spinning off a biologics company in 2012, Vivex Biomedical, Inc., that will have Revenues in excess of $65 million in 2019. He has held several board seats over the last 8 years which include such companies as Amendia, Inc., Vivex Biomedical, Inc., Valeris Medical, Inc., One Direct Healthcare Services, Inc., DSS, Funding, LLC, Phalanx Technologies, LLC and POE Management, LLC. He is currently acting as Chairman of United in Gaming, Inc. a new E-Sport Gaming Platform “Gather.gg” with a focus on the casual gamers.

Before Amendia, Mr. Smith held an Executive Vice President position at Synovus Securities, Inc., which is affiliated with Synovus Financial Corporation (Ticker Symbol on NYSE – SNV), a $30 billion financial institution. Mr. Smith was also a Senior Vice President at Morgan Keegan, Inc., which was owned by the $80 billion Regions Bank (Ticker Symbol on NYSE -RF). His experience included managing the Investment Portfolio, Funding Solutions and interest rate risk in the balance sheets of small to mid-sized financial institutions throughout the U.S. as well as sitting on Synovus Financial Corporation’s Asset/Liability Committee, which oversaw the funding of the balance sheet and the management of their $3 billion fixed income portfolio. Before serving as CEO, Jeff advised over 30 community banks with total fixed income portfolio assets of more than $1.5 billion and provided investment banking services to community banks and their clients. In addition, he has an extensive background in providing alternative funding solutions for small to mid-sized companies and community bank clients throughout the Southeast.

Jeff is a graduate of the Georgia Banking School and the University of Georgia, where he received a Bachelor’s Degree in Business Administration with a Major in Finance. Jeff has been married to Amy for 32 years and they have two boys and a daughter-in-law.